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Gestational trophoblastic disease (GTD) describes a spectrum of dis-
orders from benign to malignant arising from an aberrant fertilization
event, whereby trophoblastic tissue proliferates abnormally. While the
biology and management of GTD entities such as hydatidiform moles
and choriocarcinoma are relatively well described, lesions of the inter-
mediate trophoblast, which includes placental site trophoblastic tumor
(PSTT) and epithelioid trophoblastic tumor (ETT) are rarer, and thus
poorly understood. Over a 25-year period at Charing Cross Hospital, a
tertiary GTD center, only 2% of total GTD were classiﬁed as PSTT
(Papadopoulos et al., 2002).
Intermediate trophoblastic lesions usually present as locally ad-
vanced disease conﬁned to the uterus. However approximately 10–
15% of cases present with symptomatic distant metastatic disease
(Shih & Kurman, 2001). Over 50% of cases have a normal antecedent
term-pregnancy (Papadopoulos et al., 2002). Unlike choriocarcinoma,
b-HCG is often only marginally elevated in intermediate trophoblastic
tumors and is a poor reﬂection of disease burden. Intermediate tropho-
blastic tumors are much less chemo-responsive than their choriocarci-
noma counterparts and thus metastatic disease often portends a poor
prognosis (Shih & Kurman, 2001).
Choriocarcinoma is the most malignant end of the spectrum among
GTDs and commonly presents with metastatic disease, most frequently
in the lungs (80%), followed by vagina (30%), pelvis (20%), liver (10%)
and brain (10%) (McDonald & Ruffolo, 1983). Intra-cardiac metastasis⁎ Corresponding author at: Royal Brisbane and Women's Hospital, Butterﬁeld Street,
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metastases were found present in 4% of choriocarcinomas (Ober et al.,
1971). Almost invariably, the diagnosis of cardiac metastasis is made
post-mortem rather than ante-mortem (Bozaci et al., 2005).We present
a unique case of a 3rd trimester patient presenting with disseminated
disease including an intra-cavitary cardiac metastasis, from an interme-
diate trophoblastic tumor of unspeciﬁed subtype.2. Case report
A 33-year-old lady (G3P1) of Filipino origin presented 33 weeks
gestation with a 1-week history of haemoptysis and 5 weeks history of
progressive dyspnoea. Her previous obstetric history included a termina-
tion with a previous partner 11 years ago; and an uneventful term preg-
nancy 20 months previously with her current partner. She was a life-
long non-smoker with no previous history of malignancy. Her initial
chest x-ray revealed a large right lower-lobe pulmonary mass with me-
diastinal extension (Fig. 1A). A subsequent CT chest showed a 7 cm right
lower-lobe mass, with extension into the left atrium via the pulmonary
veins and extensivemediastinal lymphadenopathy (Fig. 1B). A transtho-
racic echocardiogram (Fig. 1C) showed a 2.7 × 4.5 cm mass in the left
atrium obstructing pulmonary venous inﬂow from the left lower and
middle pulmonary veins. The patient underwent a Caesarian-section at
34/40 weeks and delivered a healthy baby boy, who went on to achieve
normal developmental milestones. She was also noted to have a rapidly
growing scalp lesion, which was biopsied day 1 post Caesarian-section.
The scalp biopsy showed a poorly differentiated tumor composed of
large pleomorphic epitheliod cells. The tumor was negative for TTF1,
CK8/18, P40, Melan A, PAX8 and OCT4.
Macroscopically the placenta showed multiple cream to pale nodu-
lar lesionsmeasuring 2mm to 15mm in diameter (Fig. 2A). The placen-
ta histology revealed a high-grade tumor with epithelioid and spindle-
shaped morphologies with no tumor necrosis or hemorrhage. Mitoses
were readily seen. Prominent tumor-inﬁltrating neutrophils were
present.
An extensive panel of immunohistochemistry was performed on
the placental tumor nodules to clarify the primary site. The tumor la-
beled for vimentin but not for epithelial markers (CK8/18, CK19,the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1.A: Initial CXR: large right lower lobe pulmonarymass withmediastinal extension B: CT chest: 7 cm right lower lobemass with extension to the left atrium via the pulmonary veins
C: Transthoracic echocardiogram: 2.7 cm × 4.5 cm mass in left atrium obstructing pulmonary venous inﬂow from left middle and lower pulmonary veins.
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GATA3, PLAP, GPL, inhibin, OCT4, SALL4, CD117). It was also negative
for melanocyte-lineagemarkers (S100, Melan A, MITF, HMB45). Spe-
ciﬁc markers to lung (TTF1, Napsin), renal (CD10, PAX8), gynecolog-
ical and breast tumors (ER, PR, HER2) were also negative.
Choriocarcinoma was excluded on the basis of the comparatively
low Ki67 index (25% versus N50%) and the morphology of tumor nod-
ules. The scalp lesion biopsied matched the placental tumor in
morphology.
On H&E morphology alone, areas of epithelioid morphology with
pleomorphic tumor giant cells resembled epithelioid type intermediatetrophoblastic (Fig. 2B); whilst areas of spindle-shaped morphology re-
sembled placental type trophoblastic tumor (Fig. 2C). Metastatic pleo-
morphic sarcoma was considered and excluded.
Based on clinical presentation, patient demographics, pattern of
tumor spread, intra-departmental morphological review of the tumor
and consensus of the oncology team, this tumor, was considered for
pragmatic reasons, to be a trophoblastic tumor of unspeciﬁed subtype
with a null phenotype.
The patient's post-partum serum b-HCG 3-days post delivery
remained elevated at 860 iu/L. An MRI brain immediately post-partum
revealed asymptomatic brain metastasis, with 2 enhancing lesions in
Fig. 2. A: Macroscopic appearance of placenta, showing multiple cream to pale nodular lesions measuring 2 mm to 15 mm in diameter B: Areas of epithelioid morphology with
pleomorphic multinucleate tumor giant cells, resembling a chorionic-type intermediate trophoblastic lesion such as ETT C: Spindle-shaped morphology, resembling an implantation
site intermediate trophoblastic lesion such as PSTT.
Fig. 3. A: PET Scan: widespread FDG avidity consistent with pulmonary, pericardial, mediastinal nodal, cerebral, hepatic, adrenal, bony, breast and subcutaneous metastasis B: CT Brain:
multiple haemorrhagic supra and infra-tentorial brain metastasis.
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Table 1
Cases in the literature of cardiac metastasis from gestational trophoblastic tumors.
Author Year of
publication
Pt
Age
Preceeding
gestation
GTD History Histology Site and nature of
cardiac metastasis
Other sites of
metastasis
Management Outcome
MacLowry
et al.(MacLowry
& Roberts, 1966)
1966 28 Term
pregnancy
Yes
Previous molar
pregnancy terminated
5 years ago
Choriocarcinoma Left atrium.
Extension from right lung into
pulmonary vein to left atrium, thru
mitral oriﬁce
Lung, spleen, liver, kidney, small
intestine, brain, perineum
Craniotomy for
brain metastasis
Metrotrexate +
Prednisolone
Died 3 weeks after diagnosis from
brain metastasis
Akaike et al.(Akaike
et al., 1977)
1977 29 Molar
pregnancy 2
years prior
Yes Choriocarcinoma Left ventricle.
8 cm lesion from base to apex of left
ventricle.
Left anterior descending artery
embedded in tumor.
Presented with ST elevation
myocardial infarction.
Cardiac rupture causing cardiac
tampondade
Lung, kidney, brain Metrotrexate
Actinomycin D
Vinblastin
Died 11 months after diagnosis from
cardiac tamponade 2ndary to cardiac
rupture
Seigle et al.(Seigle
et al., 1987)
1987 28 Term
Pregnancy
No Choriocarcinoma Left ventricle apex Lungs, Spleen, GI tract, kidneys,
brain (oncotic aneurysms)
Nil Died 23 days after presentation from
haemorrhagic brain metastasis
Kishore
et al.(Kishore
et al., 1992)
1992 27 Unknown Unknown choriocarcinoma Left atrium extending to
pulmonary veins
Brain Atrial mass
excision
Methotrexate +
Doxorubicin
Died 12 days post cardiac surgery
from brain metastasis
Perroni
et al.(Perroni
et al., 1993)
1993 22 Term No choriocarcinoma Right ventricle thru pulmonary
valve
Ventricular mass
excision
EMA-CO ×12,
intrathecal
methrotrexate
Disease free at 4 years
Bohlmann
et al.(Bohlmann
et al., 2002)
2002 41 Term No choriocarcinoma Left atrium with obstruction of left
pulmonary vein
Pulmonary hypertension
Lung, kidneys, liver, spleen,
brain
Left atrial mass
excision
9× EMA-CO
Disease free at 1 year
Bocazi
et al.(Bohlmann
et al., 2002)
2005 53 Miscarriage
at 8/40
Not
pathological
examined
Unknown choriocarcinoma Right ventricle Lungs,
Tumor pulmonary emboli
4× EMA-CO,
4× EMA-EP
Disease free at 6 months
Present case 2015 33 Term Unknown
Previous miscarriage
Intermediate
trophoblastic tumor,
unclassiﬁed
Left atrium obstruction of
pulmonary vein
Lungs, liver, adrenal, bone,
breast, subcutaneous
mediastinal nodes, brain
6× EMA-CO
2× EMA-EP
Died 4½ months post diagnosis from
haemorrhagic brain metastasis
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partum further demonstrated widespread FDG-avid disease consistent
with pulmonary, pericardial, mediastinal nodal, hepatic, adrenal, bony,
breast and subcutaneous metastasis (Fig. 3A).
Multi-agent chemotherapy with EMA-CO (etoposide, methotrexate,
actinomycin D, cyclophosphamide and vincristine) was commenced 6-
days post Caesarian-section. The patient was given high dose IV metho-
trexate 1000mg/m2 for central nervous system (CNS) penetration. Due
to the known left atrial tumor deposit, she was therapeutically anti-
coagulated with enoxaparin to mitigate risk of systemic emboli/stroke.
Our patient completed 6 cycles of EMA-COwith initially an excellent
clinical and biochemical response to treatment. Her b-HCG dropped to a
nadir of 1.7 iu/L. A restaging PET scan showed a partial response, with
signiﬁcant interval improvement in volume ofmetastatic disease. How-
ever residual FDG-avid disease in the lungs andmediastinal nodes were
noted. A follow-up echocardiogramshowed near complete resolution of
her cardiac lesion.
Unfortunately, 3months after commencing EMA-CO, the patient's b-
HCG had started to rise again from 1.7 iu/L to 18 iu/L. A repeatMRI brain
showed near resolution of the large left frontal-lobemetastasis, but om-
inously the presence of innumerable new scattered enhancing lesions
throughout both hemispheres ranging from 1 to 4 mm in size, sugges-
tive of diffuse CNS disease.
The patient's chemotherapy was switched to second line EMA-EP
(etoposide, methotrexate, actinomycin D, cisplatin). After two cycles of
EMA-EP, the patient had a biochemical response with her bHCG
decrementing from 18 iu/L to 1.5 iu/L. However her treatment was com-
plicatedbyneutropenic line-sepsiswith sternotrophomonasbacteraemia,
which compromised her dose intensity.
Haemotology was consulted regarding consideration of stem-cell
collection with view to autologous transplantation rescue. However in
the interim, she presented with a 3-day history of headache, vomiting,
homonymous hemianopia and altered level of consciousness. A CT
brain demonstrated multiple haemorrhagic brain metastasis both
supra and infra-tentorially, with signiﬁcantmass effect (Fig. 3B). Thera-
peutic enoxaparin was immediately ceased. Despite high dose dexa-
methasone and whole brain radiotherapy, she rapidly deteriorated
from overwhelming intracranial disease and was subsequently palliat-
ed. She succumbed to her disease four and a halfmonths after diagnosis.
An autopsy was not performed.
3. Discussion
Our patient presented during 3rd trimester of a normal pregnancy,
with disseminated disease, including intra-cardiac metastasis, from an
intermediate trophoblastic malignancy. After an initial response to
EMA-CO, her disease became rapidly chemo-refractory and she died
due to CNS failure.
Cardiacmetastasis as a manifestation of GTD has only been reported
in the literature on seven occasions to our knowledge (Table 1), with all
cases documented as aggressive choriocarcinoma histology. Our case is
unique, being an intermediate trophoblastic malignancy of unspeciﬁed
subtype.
From previously described cases, cardiac metastasis seems never to
be an isolated ﬁnding in GTD, but is almost always associated with dis-
seminated multi-organ disease, including pulmonary and CNSmetasta-
sis (Bozaci et al., 2005; Seigle et al., 1987; MacLowry & Roberts, 1966;
Akaike et al., 1977; Bohlmann et al., 2002). Mirroring our own case,
ﬁve out of the seven cases of choriocarcinomadescribed in the literature
also manifested in left sided cardiac involvement, often with extension
to or obstruction of the pulmonary veins (MacLowry & Roberts, 1966;
Akaike et al., 1977; Bohlmann et al., 2002; Kishore et al., 1992). In the
majority of cases, haemorrhagic CNS disease was the cause of death
(Seigle et al., 1987;MacLowry & Roberts, 1966; Kishore et al., 1992); in-
cluding a case of multiple cardio-embolic oncotic aneurysms, without
parenchymal brain invasion (Seigle et al., 1987). Only one casedescribed in Japan, died directly as result of cardiac involvement with
a trans-mural infarction causing left ventricular rupture and cardiac
tamponade (Akaike et al., 1977).
Cases in the literature prior to the 1990s invariably had poor out-
comes (MacLowry & Roberts, 1966; Akaike et al., 1977; Kishore et al.,
1992), with cardiac surgery usually futile (Kishore et al., 1992) and
the diagnosis of GTD oftenmade post-mortem.With the advent of effec-
tive chemotherapeutic regimens such as EMA-CO (Bower et al., 1997),
prolonged survival has been achievable in isolated cases of cardiac me-
tastasis in choriocarcinoma from either chemotherapy alone (Bozaci
et al., 2005) or combination with cardiac surgery (Bohlmann et al.,
2002; Perroni et al., 1993).
Unlike choriocarcinoma, the FIGO prognostic score(Kohorn, 2001) is
of little value in intermediate trophoblastic tumors, where prognosis is
largely governed by anatomical stage. Our case highlights the chemo-
insensitivity of intermediate trophoblastic tumors. The b-HCG was
only modestly elevated in our patient, which is typical for PSTT or ETT.
Although the b-HCG trend still appeared to correlate as a useful marker
for treatment response with regards to systemic disease for our patient,
it ultimately turned out to be a poor indicator for CNS relapse.
The pathological features of the tumor in our case were difﬁcult to
classify precisely, exhibiting features of both PSTT and ETT. We came
to the diagnosis of an intermediate trophoblastic tumor of unclassiﬁed
subtype on pragmatic grounds. Previously, similar unclassiﬁed interme-
diate trophoblastic tumors to our case have also been described to cause
metastatic disease, including pneumothoraces in two case reports
(Multani et al., 2015; Barnardt & Fourie, 2011).
In conclusion, although rarely encountered, cardiac metastasis can
be a feature of disseminated trophoblastic malignancy. Intermediate
trophoblastic tumors are a rare chemo-resistant variant of gestational
trophoblastic disease, for which more experience and better therapies
are needed. The management of haemorrhagic brain metastasis in
drug resistant disease is particularly challenging.
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